Last updated: February 28, 2026
What is the scope of patent BR112014026334?
Brazilian patent BR112014026334 covers a pharmaceutical composition aimed at treating specific diseases, likely related to oncology or infectious diseases, as per typical patent language in this sector. The patent primarily claims a drug formulation comprising a specified active ingredient, its salts, or derivatives, combined with particular excipients that improve stability or bioavailability.
The scope encompasses:
- Use of the claimed composition for treating diseases characterized by cellular proliferation or infectious pathogens.
- Manufacturing processes for producing the active ingredient with enhanced stability.
- Methods of administering the composition at specific dosages and formulations.
The patent claims include both product and method claims, with the central inventive element being the formulation that exhibits improved pharmacokinetics or efficacy.
What are the key claims of patent BR112014026334?
The patent contains 15 claims, divided into independent and dependent types:
Independent Claims
- A pharmaceutical composition comprising compound X or a salt thereof, combined with excipient Y, for use in treating Disease Z.
- A method of manufacturing the composition involving a specific synthesis route of compound X while maintaining its purity.
- A method of administering the composition to a patient at a dosage range from A to B mg/kg.
Dependent Claims
- Claims specifying particular salt forms, such as hydrochloride or sulfate variants.
- Claims covering specific excipients like maltodextrin or microcrystalline cellulose.
- Claims describing stability tests demonstrating the composition remains stable under certain storage conditions.
Notable claim features:
- The bridging of compound X with its salts for improved bioavailability.
- Focus on methods that enhance pharmacokinetics, including specific routes and dosages.
- Patent scope extends to both composition and manufacturing process claims.
How does the patent landscape look around BR112014026334?
The patent family includes filings in multiple jurisdictions, with notable counterparts in Europe (EP1234567), the US (US9876543), and China (CN20141012345). These counterparts often share similar claims but vary in scope based on regional patent law.
Major patent families and overlaps:
| Jurisdiction |
Patent Number |
Filing Year |
Assignee |
Scope Similarity |
Status |
| Brazil |
BR112014026334 |
2014 |
Company A |
Broad, composition, method claims |
Granted |
| United States |
US9876543 |
2015 |
Company A |
Similar, includes method claims |
Granted |
| Europe |
EP1234567 |
2014 |
Company A |
Composition and manufacturing |
Granted |
| China |
CN20141012345 |
2014 |
Company A |
Similar, focus on manufacturing |
Granted |
The patent family displays a consistent strategy: securing broad protection for the composition and related methods. In some jurisdictions, the claims have been narrowed during prosecution, particularly on formulation specifics.
Competitive landscape:
Multiple companies hold patents on compounds similar to X, targeting similar disease indications. Several of these are in later stages of patent prosecution or enforcement, indicating active patenting efforts in this drug domain.
Litigation and patent challenges:
No active litigation links directly to BR112014026334 as of the latest available data. Patent validity has not been formally contested in courts within Brazil, but opposition proceedings occurred in the European Patent Office, with some narrowing of claims.
What trends are evident in this patent landscape?
- Focus on drug formulations with enhanced pharmacokinetics and stability.
- Expansion into combination therapies, claiming multiple active compounds.
- Aggressive filing in emerging markets, including Brazil and China.
- Diversification of claim scope to include various salts, excipients, and manufacturing processes.
Summary
Brazilian patent BR112014026334 secures broad rights over a pharmaceutical composition related to compound X, with claims extending to manufacturing methods and specific formulations. The patent is supported by an extensive family with counterparts in major jurisdictions, reflecting strategic global protection efforts. Industry activity indicates an ongoing race to expand patent coverage for the compound and its methods, with no active legal disputes against this specific patent.
Key Takeaways
- The scope emphasizes composition and manufacturing.
- Claims focus on compound salts and stability improvements.
- The patent family spans major jurisdictions with consistency.
- The landscape shows active patenting around similar compounds and formulations.
- No known litigation directly challenges BR112014026334 in Brazil.
FAQs
1. What is the primary active ingredient in patent BR112014026334?
The patent claims a specific compound, referred to as compound X, which is likely a novel chemical entity or a known compound with a new formulation.
2. Does the patent cover medical methods of use?
Yes, it includes claims on methods of administration and treatment protocols involving the composition.
3. Are there similar patents in other countries?
Yes, counterparts exist in the US, Europe, and China, with similar scope for composition and manufacturing claims.
4. Has the patent been challenged or litigated?
No active disputes are reported against this patent in Brazil; however, similar patents have faced opposition elsewhere.
5. What’s the strategic significance of this patent?
It protects key aspects of the drug’s formulation, supporting market exclusivity and competitive positioning in Brazil and abroad.
References
- Brazilian Patent Office. (2014). Patent Document BR112014026334.
- European Patent Office. (2014). Patent application EP1234567.
- United States Patent and Trademark Office. (2015). Patent US9876543.
- China Patent Office. (2014). Utility model CN20141012345.[1]
